Application of Imaging Technologies in Breast Cancer Detection: A Review Article.

Application of Imaging Technologies in Breast Cancer Detection: A Review Article.
复制标题

DOI:
10.3889/oamjms.2019.171
复制
发表时间:
2019-03-15
影响因子:
--
通讯作者:
Younesi, Ladan
Younesi, Ladan
中科院分区:
其他
文献类型:
--
作者:
Lima, Zeinab Safarpour;Ebadi, Mohammad Reza;Younesi, Ladan

文献摘要

被引文献

相似文献

在所有阶段的癌症管理中使用的技术之一是多重生物医学成像。影像作为肿瘤临床方案的重要组成部分,可以提供有关肿瘤的形态、结构、代谢和功能的各种信息。影像技术与其他研究仪器的应用,包括体液分析和体外组织,将有助于临床决策。混合成像技术可以提供用于改善分期和治疗计划的补充信息。成像的目的是找到微创治疗方法,以取得更好的效果并减少副作用。也许,降低某些癌症死亡率的最重要因素是通过基于成像的筛查来早期诊断癌症。女性最常见的癌症是乳腺癌。它被认为是导致女性癌症死亡的第二大原因,因此仍然是一个重要的医疗和社会经济问题。医学成像一直是乳腺癌护理的一部分,并已用于癌症管理的所有阶段,从检测和分期到治疗监测和治疗后随访。在乳腺癌的术前分期中,根据乳房影像进行必要的操作。乳房成像的一般术语是指乳房超声检查、乳房X光检查和乳腺的磁共振断层扫描(MRM)。技术的进一步发展将导致提高成像速度以满足生理过程的要求。乳腺癌诊断中的一个问题是敏感性限制。为了克服这一局限,使用了互补的成像检查,传统上包括筛查超声、乳房X光检查和超声联合检查。靶向成像和治疗剂的发展需要学术环境和行业之间的密切合作,如生物技术、IT和制药行业。
One of the techniques utilised in the management of cancer in all stages is multiple biomedical imaging. Imaging as an important part of cancer clinical protocols can provide a variety of information about morphology, structure, metabolism and functions. Application of imaging technics together with other investigative apparatus including in fluids analysis and vitro tissue would help clinical decision-making. Mixed imaging techniques can provide supplementary information used to improve staging and therapy planning. Imaging aimed to find minimally invasive therapy to make better results and reduce side effects. Probably, the most important factor in reducing mortality of certain cancers is an early diagnosis of cancer via screening based on imaging. The most common cancer in women is breast cancer. It is considered as the second major cause of cancer deaths in females, and therefore it remained as an important medical and socio-economic issue. Medical imaging has always formed part of breast cancer care and has used in all phases of cancer management from detection and staging to therapy monitoring and post-therapeutic follow-up. An essential action to be performed in the preoperative staging of breast cancer based on breast imaging. The general term of breast imaging refers to breast sonography, mammography, and magnetic resonance tomography (MRT) of the breast (magnetic resonance mammography, MRM). Further development in technology will lead to increase imaging speed to meet physiological processes requirements. One of the issues in the diagnosis of breast cancer is sensitivity limitation. To overcome this limitation, complementary imaging examinations are utilised that traditionally includes screening ultrasound, and combined mammography and ultrasound. Development in targeted imaging and therapeutic agents calls for close cooperation among academic environment and industries such as biotechnological, IT and pharmaceutical industries.